Trial Profile
Deep profiling of lipid changes in patients with active ulcerative colitis treated with either tofacitinib or infliximab
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2019
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Tofacitinib (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics
- Acronyms LIPID
- 17 Nov 2018 New trial record